23798 related articles for article (PubMed ID: 16245793)
1. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
4. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
5. [Non-tuberculous mycobacteriosis. What has been coming out].
Kajiki A
Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
[TBL] [Abstract][Full Text] [Related]
6. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
7. [Up-to-date understanding of tuberculosis immunity].
Mitsuyama M; Akagawa K; Kobayashi K; Sugawara I; Kawakami K; Yamamoto S; Okada Z
Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
[TBL] [Abstract][Full Text] [Related]
8. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
Okada M; Kita Y
Kekkaku; 2010 Jun; 85(6):531-8. PubMed ID: 20662249
[TBL] [Abstract][Full Text] [Related]
9. [Exogenous re-infection in tuberculosis].
Tsuchiya T
Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
[TBL] [Abstract][Full Text] [Related]
10. [New era in molecular epidemiology of tuberculosis in Japan].
Takashima T; Iwamoto T
Kekkaku; 2006 Nov; 81(11):693-707. PubMed ID: 17154049
[TBL] [Abstract][Full Text] [Related]
11. [Future prospects of molecular epidemiology in tuberculosis].
Matsumoto T; Iwamoto T
Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors in innate immunity.
Takeda K; Akira S
Int Immunol; 2005 Jan; 17(1):1-14. PubMed ID: 15585605
[TBL] [Abstract][Full Text] [Related]
13. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
14. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
Ogawa K; Sano C
Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of non-tuberculous pulmonary mycobacteriosis].
Sakatani M; Nakajima Y
Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
[TBL] [Abstract][Full Text] [Related]
16. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis.
Reiling N; Ehlers S; Hölscher C
Immunol Lett; 2008 Feb; 116(1):15-23. PubMed ID: 18191460
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs.
Jo EK
Curr Opin Infect Dis; 2008 Jun; 21(3):279-86. PubMed ID: 18448973
[TBL] [Abstract][Full Text] [Related]
18. [Protective immunity against Mycobacterium tuberculosis].
Kawamura I
Kekkaku; 2006 Nov; 81(11):687-91. PubMed ID: 17154048
[TBL] [Abstract][Full Text] [Related]
19. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.
Means TK; Wang S; Lien E; Yoshimura A; Golenbock DT; Fenton MJ
J Immunol; 1999 Oct; 163(7):3920-7. PubMed ID: 10490993
[TBL] [Abstract][Full Text] [Related]
20. Novel prophylactic and therapeutic vaccine against tuberculosis.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Inoue Y; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
Vaccine; 2009 May; 27(25-26):3267-70. PubMed ID: 19200841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
